This New Jersey bill establishes the "Privacy Protection Act" to limit how government agencies and healthcare facilities collect and share certain personal information. It prohibits them from requesting details like immigration status, citizenship, social security numbers, or tax IDs unless necessary for specific public services, benefits, or healthcare delivery (with healthcare exceptions for patient safety). The bill requires written consent in the person's preferred language for sharing any collected data, detailing exactly what will be shared, why, and confirming consent is voluntary without retaliation. It also bans selling or sharing vehicle license plate data except under court orders, subpoenas, or with explicit written consent, and mandates government entities to update privacy policies within one year.
This bill, "Anthony Maruca’s Law," requires New Jersey law enforcement officers who have access to epinephrine auto-injectors to complete approved training on emergency administration. It allows police departments to provide these devices to officers for use during official duties, storing them in vehicles or medical kits per health department guidelines. The law directly affects officers employed by police departments and mandates certification of training completion for those using the devices. Key provisions include the training requirement and authorization for departments to maintain the injectors, with no new funding or cost mandates specified.
S 3023 protects residents of long-term care facilities (like nursing homes and assisted living facilities) and long-term acute care hospitals by preventing facility staff, owners, or financially benefiting parties from managing residents' finances or serving as their legal representatives. It requires facilities to use standardized admission forms developed by the Department of Health, with input from stakeholders, and prohibits residents from signing non-standard documents during admission. The bill also gives residents a legal right to sue if facilities violate these protections, allowing recovery of damages, attorney fees, and punitive penalties for financial exploitation. These changes directly affect residents, their families, and facility operators by creating new safeguards against financial abuse during admission and care.
S 712 requires New Jersey's Department of State to create a public "Reproductive Health Travel Advisory" to help residents traveling while pregnant make informed decisions. The advisory will categorize all U.S. states using a color-coded system: "Blue" (full access without legal risk), "Yellow" (restricted access with potential legal consequences), and "Red" (extreme restrictions risking denial of emergency care). It will detail each state's laws on abortion bans, waiting periods, insurance coverage, and legal protections for patients and providers. The advisory must be posted on the state website and updated whenever another state changes its reproductive healthcare laws. This directly affects New Jersey residents who may need to travel during pregnancy for medical emergencies.
This bill requires midwives and physicians who provide obstetric care to give pregnant patients written, evidence-based information about all available birthing options (including hospital births, home births, scheduled procedures, and associated health risks) before labor begins. The information must be provided in English and at least seven common non-English languages spoken by limited-English-proficiency patients in New Jersey, based on census data. Providers must also offer annual language-appropriate education on these options during pregnancy. The law applies directly to pregnant patients receiving care from certified midwives or physicians in New Jersey, aiming to improve informed decision-making.
This bill requires New Jersey's Department of Health (DOH) to launch a mobile cancer screening program within 180 days of its effective date. The program will use staffed mobile vehicles deployed across the state's northern, central, and southern regions, each operated by at least one qualified healthcare professional who determines screening methods based on their expertise and available equipment. The bill appropriates $100,000 from the state General Fund to fund this initiative and mandates a report to the Governor and Legislature within two years, summarizing results and suggesting future legislative action. The program directly affects New Jersey residents, particularly those in underserved areas who may gain easier access to cancer screenings.
This bill requires all licensed general and special hospitals in New Jersey to create and implement evidence-based protocols for early sepsis recognition and treatment. The protocols must cover screening, treatment guidelines (with separate adult and pediatric components), infection source identification, antibiotic timing, and exclusion criteria for inappropriate cases. Hospitals must submit protocols to the Department of Health within 120 days of enactment, train staff regularly, and annually report data to track adherence and mortality rates for quality improvement. The law focuses on standardizing care for a life-threatening condition that can cause organ damage or death if untreated.
This bill (S 2980) requires nursing home owners to submit detailed financial and ownership information before transferring ownership or delegating management to third parties. It mandates disclosure of 100% ownership structures, organizational charts, and third-party service providers paying over $200,000 annually, along with resolution of outstanding Medicaid debts. The Department of Health must publicly post applications (with privacy redactions) and allow a 30-day public comment period. These changes aim to increase transparency for prospective buyers and the public while ensuring new owners meet financial and operational standards.
This bill adds 7-hydroxymitragynine (7-OH), a psychoactive compound found in Kratom, to New Jersey's Schedule I list of controlled substances. It directly affects anyone possessing, manufacturing, distributing, or using 7-OH in the state. Under the law, 7-OH would be classified as a substance with "high potential for abuse" and "no accepted medical use," making it illegal for non-medical purposes. Possession of 1 ounce or more would be a second-degree crime, while smaller amounts would be a third-degree crime under New Jersey's drug laws.
S 2243 requires every public college and university in New Jersey to create a menstrual equity task force within six months of the law's effective date. The task force, appointed by each institution's president and including diverse campus stakeholders (students, faculty, housing, health centers, etc.), must develop a detailed plan for free menstrual product access within six months. The plan must cover product needs, distribution locations, costs, and a 12-month implementation timeline. Institutions must implement the approved plan within one year, ensuring equal access to menstrual products while reducing stigma. The bill defines "menstrual equity" as removing barriers to care and addressing stigma around menstruation.
